ADMET
30 June 2014 - 01 July 2014
The topics covered in this conference will focus on the role of ADMET in drug development. We will also be looking at the perdiction value of toxicity while addressing in silico and in vivo methods. there will also be a focus on biologics v/s small molecules in ADMET and an update on drug transporters. Attendees will be at a distinct advantage and hear from the most important people in the field on themes including Predictive ADME, Screening Approaches, Pre-clinical Screening Approaches, and Predictive Toxicology, emerging issues such as, regulatory changes and Drug-Drug interactions.
Marriott Hotel, Regents Park, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/conference/admet
Robotics and Automation 2014
01 July 2014
FESTO Applied Automation UK headquarters, Northampton is the setting for the 1 Day – ELRIG - Robotics & Automation show being held on 1st July.
The show will be focusing on the components and technologies used in laboratory automation applications.
It will be an opportunity to listen and discuss the implementation of automation components with colleagues and suppliers. A varied selection of full length and snapshot talks will be presented to give scientific and engineering users an understanding of what is available to automate experiments.
This conference is aimed at anyone who works in the life sciences laboratory environment and who would benefit from the implementation of these technologies. We intend to cover innovative technologies such as software for the automated process (control & data), robotic and process simulation and automation tools (vision and transportation).
FESTO Applied Automation UK headquarters, Northampton
http://www.elrig.org
RICT 2014 Interfacing Chemical Biology and Drug Discovery
02 July 2014 - 04 July 2014
The scientific programme will include over 25 plenary lectures by internationally recognised scientists and will focus on "Interfacing Chemical Biology and Drug Discovery", covering the main stages of modern drug discovery:
Targets and Pathways
Novel Approaches / Tools to Understand Molecular Interactions (Unravelling Biological Pathways)
Predictive Tools in Drug Discovery
Exploring Molecular Space
Peptides / Peptidomimetics in Drug Discovery
Case Studies
As per its tradition, the scientific committee will ensure the high quality and diversity of the scientific programme, together with the accessibility of the meeting to MSc and PhD students. For the latter, an advantageous registration fee will be proposed. Moreover, a special career session will be organised with industrial and academic participants.
Rouen's Law Faculty (Faculté de Droit), Rouen, Normandy, France
http://www.ldorganisation.com/v2/page/rict_2014_international_conference_medicinal_chemistry/products.html
Novel Cancer Therapeutics Summit 2014
07 July 2014 - 08 July 2014
This summit includes two parallel conferences bringing together experts from industry, academia and government to discuss emerging targets, therapeutics, progress in cancer immunotherapy, and strategies against cancer. In addition, focuses on business development trends, partnership opportunities, value maximization/capital efficiency, and the return of biotech IPOs will also be discussed.
Hyatt Regency Boston, Boston, MA, USA
https://www.gtcbio.com/conference/novel-cancer-therapeutics-summit-overview
5th Cancer Targets & Therapeutics Conference
07 July 2014 - 08 July 2014
With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets and therapeutics provide new opportunities for the prevention and treatment of several major disease systems. The 5th Cancer Targets & Therapeutics Conference, taking place on July 7-8, 2014 in Boston, MA will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials, working to identify and exploit advances in the field in order to deliver products with a meaningful clinical impact. Both cutting-edge researchers and those who guide its commercial development will be on-hand to share their knowledge and insights as to how therapeutic cancer targets are identified, and how this research translates into meaningful therapeutics that benefit patients living with cancer.
Hyatt Regency Boston, Boston, MA, USA
http://www.gtcbio.com/conference/cancer-targets-overview
3rd Oncology Partnering & Deal Making
07 July 2014 - 08 July 2014
This event is a partnership and business development conference that provides an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations and learn about relevant issues in oncology that will affect the industry. Experts in the field of oncology will present on the latest discoveries, novel technologies, business development trends, markets, partnership opportunities, alliance management, value maximization vs. capital efficiency, and IPO. There will be a mix of presentations and interactive panel discussions so join your business development colleagues at this unique partnering forum!
Hyatt Regency Boston, Boston, MA, USA
http://www.gtcbio.com/conference/oncology-partnering-overview
Lyophilisation
07 July 2014 - 08 July 2014
Further to the success of diverse pharmaceutical events, SMi is very pleased to present the 2nd annual Lyophilisation conference on 7-8 July 2014, London. This event will provide an update on methodologies for lyophilisation and examine how to mitigate risks in production. Gain practical information and tools which you can use and apply in the workplace.
Marriott Hotel, Regents Park, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/lyophilisation-freeze-drying-pharma-andbiopharma
European BioNetworks Summit
07 July 2014 - 08 July 2014
Following on from a portfolio of successful pharmaceutical events, SMi are proud to present their European Bionetwork Summit, Monday 7th – Tuesday 8th July, 2014, Central London. This important and timely meeting will allow biotech, pharma, academic and funding organisations to evaluate how they partner with other stakeholders in the field to accelerate research and reduce costs.
Marriott Hotel, Regents Park, London, UK
http://www.smi-online.co.uk/bio-networks14.asp
The Enabling Future Pharma Conference: The New Role of the NIH, Academic and Patient-Based Organisation in the Drug Discovery towards Rare and Neglected Diseases
09 July 2014 - 12 July 2014
Resurgence of the pharmaceutical industry to its preeminence can only be realized through Collaborative Innovation in Biomedicine. Given the complexities and the expense of pharmaceutical R&D, we can accomplish much more, in a shorter time and with less cost and duplication of effort, when the private and public sectors bring their special strengths to bear. These are challenging times, but they also offer unprecedented opportunities to form complementary and synergistic partnerships and collaborative research enterprises with an overarching goal of advancing drug discovery breakthroughs and bridge the translational gap. The overarching theme of this unique and high profile conference is to address the role of non-profits, including patient-based organizations, as catalysts in meeting the needs of patients and caregivers, and in the discovery and development of new drugs and biologics against rare and neglected diseases
Hilton Chicago Indian Lakes Resort, Bloomingdale, Chicago, USA
http://www.fusion-conferences.com/conference17.php
Allergies 2014
09 July 2014 - 10 July 2014
The programme will examine key areas such as novel approaches in the treatment of allergy, therapeutic advances, allergic pathophysiology, current update on food allergies, the future of allergen-specific immunotherapy and challenges, allergy prevention, diagnosis and drug development plus much more.
Holiday Inn Hotel, Regents Park, London UK
http://www.smi-online.co.uk/goto/allergies14.asp
Immunogenicity
14 July 2014 - 15 July 2014
The focus is on pre-clinical analysis and assessing treatments for clinical development. It will endeavour to look at the assessment of early risks in immunogenicity and the evaluation of in silico tools for determining immunogenicity. With an insight into the safety, development and validation of Monoclonal Antibodies.
Further to this, the main interest emerging is the tissue quality and preservation in which the therapeutics are being put into. The conference will evaluate what happens to them in vivo along with a regulatory perspective.
Marriott Hotel, Regents Park, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/conference/Immunogenicity